Shai Mulinari

1 – 10 of 99

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/medk-smu?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
…
9
10
next »

2025
Mark Pharmaceutical Industry Payments to Patient Organizations in Poland : Analysis of the Patterns, Evolution, and Structure of Connections
Makowska, Marta ; Mulinari, Shai ^LU and Ozieranski, Piotr (2025) In International journal of social determinants of health and health services 55(2). p.199-212
- Contribution to journal › Article
Mark Unknowns of drug company payment disclosure : why the UK needs payment transparency legislation
Ozieranski, Piotr ; Rickard, Emily and Mulinari, Shai ^LU (2025) In BMJ Evidence-Based Medicine
- Contribution to journal › Article
Mark Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed
Nilsonne, Gustav ; Wieschowski, Susanne ; DeVito, Nicholas J ; Salholz-Hillel, Maia ; Ahnström, Love ; Bruckner, Till ; Klas, Katarzyna ; Suljic, Tarik ; Yerunkar, Samruddhi and Olsson, Natasha , et al. (2025) In Journal of Clinical Epidemiology 181.
- Contribution to journal › Article
Mark Self-regulation of UK's pharmaceutical industry
Ozieranski, Piotr ; Mulinari, Shai ^LU ; Colombo, Cinzia and Mintzes, Barbara (2025) In BMJ (Clinical research ed.) 389. p.1065-1065
- Contribution to journal › Debate/Note/Editorial
Mark Det är dags att Läkartidningen slutar med läkemedelsannonser
Mulinari, Shai ^LU ; Svensson, Staffan ; Ringsten, Martin ^LU ; Bruschettini, Matteo ^LU ; Jørgensen, Karsten Juhl ; Boesen, Kim and Marx, André (2025) In Läkartidningen
- Contribution to journal › Debate/Note/Editorial
2024
Mark Race in clinical trials in Sweden: how regulatory and medical standards in clinical research trump the post-racial discourse
Mulinari, Shai ^LU and Bredström, Anna (2024) In Sociology of Health & Illness 46(2). p.315-332
- Contribution to journal › Article
Mark “Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation
Mulinari, Shai ^LU and Bredström, Anna (2024) In BioSocieties 19. p.19-36
- Contribution to journal › Article
Mark Delays in dealing with complaints against drug companies are growing, BMJ finds
Boytchev, Hristio ; Mulinari, Shai ^LU and Ozieranski, Piotr (2024) In BMJ (Clinical research ed.) 384. p.365-365
- Contribution to specialist publication or newspaper › Specialist publication article
Mark Aligning digital biomarker definitions in psychiatry with the National Institute of Mental Health Research Domain Criteria framework
Mulinari, Shai ^LU (2024) In NPP—Digital Psychiatry and Neuroscience 2.
- Contribution to journal › Article
Mark Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015 and 2019 : A content analysis
Larkin, James ; Matthes, Britta ; Azribi, Mohamed ; Kearns, Conor ; Mulinari, Shai ^LU ; Rickard, Emily ; Moriarty, Frank ; Fahey, Tom and Ozieranski, Piotr (2024) In Health Policy 149(November 2024).
- Contribution to journal › Article

« previous
1
2
3
4
…
9
10
next »